Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Gastroenteritis - Overview
Gastroenteritis - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Gastroenteritis - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Gastroenteritis - Companies Involved in Therapeutics Development
Allakos Inc
Beijing Kangleweishi Biotechnology Co Ltd
Blue Lake Biotechnology Inc
Bristol-Myers Squibb Co
Chongqing Zhifei Biological Products Co Ltd
Cocrystal Pharma Inc
Kyowa Kirin Co Ltd
Lanzhou Institute of Biological Products Co Ltd
Medicago Inc
Novo Medi Sciences Pvt Ltd
RedHill Biopharma Ltd
Regeneron Pharmaceuticals Inc
Takeda Pharmaceutical Co Ltd
Gastroenteritis - Drug Profiles
Antibodies for Gastroenteritis - Drug Profile
Product Description
Mechanism Of Action
benralizumab - Drug Profile
Product Description
Mechanism Of Action
History of Events
BLB-300 - Drug Profile
Product Description
Mechanism Of Action
cendakimab - Drug Profile
Product Description
Mechanism Of Action
History of Events
dupilumab - Drug Profile
Product Description
Mechanism Of Action
History of Events
HIL-214 - Drug Profile
Product Description
Mechanism Of Action
History of Events
lirentelimab - Drug Profile
Product Description
Mechanism Of Action
History of Events
norovirus (polyvalent, virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
norovirus [strains GI.1 + GII.4] (bivalent) vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
Norovirus Gastroenteritis - Drug Profile
Product Description
Mechanism Of Action
ondansetron hydrochloride CR - Drug Profile
Product Description
Mechanism Of Action
History of Events
rotavirus (virus like particle) vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
rotavirus vaccine - Drug Profile
Product Description
Mechanism Of Action
Gastroenteritis - Dormant Projects
Gastroenteritis - Discontinued Products
Gastroenteritis - Product Development Milestones
Featured News & Press Releases
Mar 30, 2021: Allakos Announces Multiple Presentations Related to Eosinophil and Mast Cell-Driven Diseases at the 2021 DDW Annual Meeting
Nov 12, 2019: RedHill Biopharma announces publication of RHB-102 gastroenteritis phase 3 study results in JAMA
Oct 28, 2019: Allakos Announces Multiple Presentations from Its Eosinophilic Gastrointestil Diseases Program at the American College of Gastroenterology (ACG) 2019 Annual Scientific Meeting
Aug 05, 2019: Allakos announces AK002 met all prespecified primary and secondary endpoints in phase 2 randomized, double-blind, placebo-controlled study in patients with eosinophilic gastritis (EG) and/or eosinophilic gastroenteritis (EGE)
Oct 08, 2018: Allakos presents data from its eosinophilic gastrointestil diseases program at the American College of Gastroenterology (ACG) 2018 Annual Scientific Meeting
Mar 27, 2018: RedHill Biopharma Announces Two Oral Presentations on BEKINDA 24 mg for acute gastroenteritis at the SAEM 2018 Annual Meeting
Jun 19, 2017: RedHill Biopharma to Host Conference Call on Successful Phase III Top-Line Results with BEKINDA for Acute Gastroenteritis
Jun 14, 2017: RedHill Biopharma Announces Successful Phase III Top-Line Results with BEKINDA for Acute Gastroenteritis
Apr 19, 2017: RedHill Biopharma to Host R&D Day on BEKINDA for Acute Gastroenteritis and IBS-D
Apr 18, 2017: RedHill Biopharma Receives Notice of Allowance for Two Additiol U.S. Patents Covering BEKINDA
Feb 21, 2017: RedHill Biopharma Completes Treatment of Last Patient in BEKINDA Phase III Study for Acute Gastroenteritis
Feb 13, 2017: RedHill Biopharma Announces Enrollment of Last Patient in BEKINDA Phase III Study for Acute Gastroenteritis
Jan 12, 2017: RedHill Biopharma Provides Milestone Update on Bekinda
Nov 03, 2016: RedHill Biopharma Provides Update on Ongoing Phase III and Phase II studies with BEKINDA and Expected Timing of Top-Line Results
Mar 01, 2016: RedHill Biopharma Provides Update on RHB-102
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Gastroenteritis, 2022
Number of Products under Development by Companies, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Gastroenteritis, 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Gastroenteritis - Pipeline by Allakos Inc, 2022
Gastroenteritis - Pipeline by Beijing Kangleweishi Biotechnology Co Ltd, 2022
Gastroenteritis - Pipeline by Blue Lake Biotechnology Inc, 2022
Gastroenteritis - Pipeline by Bristol-Myers Squibb Co, 2022
Gastroenteritis - Pipeline by Chongqing Zhifei Biological Products Co Ltd, 2022
Gastroenteritis - Pipeline by Cocrystal Pharma Inc, 2022
Gastroenteritis - Pipeline by Kyowa Kirin Co Ltd, 2022
Gastroenteritis - Pipeline by Lanzhou Institute of Biological Products Co Ltd, 2022
Gastroenteritis - Pipeline by Medicago Inc, 2022
Gastroenteritis - Pipeline by Novo Medi Sciences Pvt Ltd, 2022
Gastroenteritis - Pipeline by RedHill Biopharma Ltd, 2022
Gastroenteritis - Pipeline by Regeneron Pharmaceuticals Inc, 2022
Gastroenteritis - Pipeline by Takeda Pharmaceutical Co Ltd, 2022
Gastroenteritis - Dormant Projects, 2022
Gastroenteritis - Discontinued Products, 2022